87380024
Mar 21, 2017
Targeted T-cell receptor sequences, engineered T-cell receptor sequences, and therapeutics derived from natural T-cell receptor sequences for use in the treatment of cancer, autoimmune disease and infectious diseases
PharmaceuticalsScientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies
Computer and Scientific